Skip to download form
Poster

Semi-Automated Micronucleus Assay with Telomere & Centromere Staining

Re-evaluating the cytokinesis-block micronucleus assay with semi-automated scoring following PNA telomere and centromere staining — a new tool for genotoxic risk assessment.

Audience
Pharma, Biotech, Academic
Year
2023
Language
English
Format
PDF · 1 pages
Authors
F. Finot, R. M'kacher et al. (multi-centre collaboration)
Semi-Automated Micronucleus Assay with Telomere & Centromere Staining

What's inside

  • Cytokinesis-block micronucleus (CBMN) assay re-evaluated
  • PNA telomere & centromere staining
  • Semi-automated micronucleus scoring
  • Improved, higher-throughput genotoxic risk assessment

The cytokinesis-block micronucleus (CBMN) assay is a cornerstone of genotoxic risk assessment, but manual scoring is labour-intensive and expertise-dependent.

This work re-evaluates the CBMN assay using semi-automated scoring following PNA telomere and centromere staining. The approach improves the reliability and throughput of micronucleus scoring and adds mechanistic insight (aneugenic vs clastogenic events), providing a new tool for genotoxic risk assessment.

Who this is for

  • Cytogenetics and radiobiology researchers
  • Pharma genotoxicity teams
  • Academic toxicology

Recommended citation

F. Finot, R. M'kacher et al. (multi-centre collaboration) (2023). Semi-Automated Micronucleus Assay with Telomere & Centromere Staining. GenEvolutioN Technologies.